| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| BridgeBio Oncology Therapeutics, Inc. | Former Director | Common Stock | 30K | $322K | $10.72 | Aug 11, 2025 | Direct |
| BridgeBio Oncology Therapeutics, Inc. | Former Director | Class B ordinary shares | 0 | Aug 11, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| BBOT | BridgeBio Oncology Therapeutics, Inc. | Aug 11, 2025 | 2 | $0 | 4 | Aug 11, 2025 | Former Director |
| HLXB | Helix Acquisition Corp. II | Feb 8, 2025 | 0 | $0 | 3 | Feb 11, 2025 | Director |